MedTrace Logo

Role of Lung Function for Exercise Capacity in Well-trained Individuals

NCT06077019 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-04-09

No results posted yet for this study

Summary

The purpose of the project is to investigate exercise performance in humans following prolonged inhalation of beta2-agonists vilanterol + fluticasone furoate or indacaterol + mometasone furoate

Conditions

  • Exercise Performance

Interventions

DRUG

Vilanterol and Fluticasone Furoate

Participants inhale 25 µg vilanterol + fluticasone furoate daily

DRUG

Indacaterol and Mometasone Furoate

Participants inhale 125 µg indacaterol + mometasone furoate daily

DRUG

Placebo

Participants inhale placebo daily

Sponsors & Collaborators

  • Morten Hostrup, PhD

    lead OTHER

Principal Investigators

  • Morten Hostrup, PhD · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2026-07-15
Completion
2026-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06077019 on ClinicalTrials.gov